Alterity Therapeutics Limited (ATHE)

Alterity Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	15.77	34.81	28.12	9.2	14.4
Cash & Cash Equivalents	15.77	34.81	28.12	9.2	14.4
Cash Growth	-54.68%	23.80%	205.71%	-36.13%	-5.48%
Receivables	8.67	4.73	4.28	0.06	4.83
Other Current Assets	2.61	1.61	1.1	0.58	0.63
Total Current Assets	27.05	41.14	33.49	9.84	19.86
Property, Plant & Equipment	0.27	0.22	0.1	0.07	0.05
Total Long-Term Assets	0.27	0.22	0.1	0.07	0.05
Total Assets	27.32	41.36	33.59	9.91	19.91
Accounts Payable	3.52	5.08	2.5	2.07	2.72
Current Debt	0	0.06	0.03	0.03	0
Other Current Liabilities	0.86	0.68	0.54	0.61	0.6
Total Current Liabilities	4.38	5.82	3.07	2.71	3.32
Long-Term Debt	0	0.06	0.04	0	0
Other Long-Term Liabilities	0.12	0.01	0.01	0.04	0.03
Total Long-Term Liabilities	0.12	0.07	0.05	0.04	0.03
Total Liabilities	4.5	5.89	3.12	2.76	3.36
Total Debt	0	0.12	0.07	0.03	0
Debt Growth	-	78.97%	94.53%	-	-
Retained Earnings	-195.13	-181.88	-169.73	-154.42	-141.24
Shareholders' Equity	22.81	35.47	30.47	7.15	16.55
Net Cash / Debt	15.77	34.69	28.05	9.16	14.4
Net Cash / Debt Growth	-54.53%	23.67%	206.12%	-36.37%	-5.48%
Net Cash Per Share	0.01	0.01	0.02	0.01	0.02
Working Capital	22.67	35.32	30.42	7.12	16.54
Book Value Per Share	5.64	8.84	10.77	4.79	16.13

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).